(Q34729747)

4 August 2017

1 reference

title

Pharmacotherapy and medical complications of eating disorders in children and adolescents (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

James Edward Mitchell

series ordinal

2

object named as

James E Mitchell

1 reference

4 August 2017

James L Roerig

1

1 reference

PubMed ID

12109326

4 August 2017

Tricia Cook Myers

series ordinal

3

1 reference

PubMed ID

12109326

4 August 2017

John B Glass

series ordinal

4

1 reference

4 August 2017

1 April 2002

1 reference

Child and Adolescent Psychiatric Clinics of North America

4 August 2017

1 reference

4 August 2017

11

1 reference

4 August 2017

2

1 reference

4 August 2017

365-85, xi

1 reference

Acute gastric necrosis in anorexia nervosa and bulimia. Two case reports

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The superior mesenteric artery syndrome and acute gastric dilatation in eating disorders: a report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Liver and gallbladder disease before and after very-low-calorie diets

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Rapid screening for disordered eating in college-aged females in the primary care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Does fluoxetine augment the inpatient treatment of anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Open trial of fluvoxamine in the treatment of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Lithium in adult anorexia nervosa. A pilot report on two patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Marked symptom reduction in two women with bulimia nervosa treated with the testosterone receptor antagonist flutamide.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The use of citalopram in an integrated approach to the treatment of eating disorders: an open study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Upper gastrointestinal tract dysfunction in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Biologic effects of transdermal estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Role of Insulin-Like Growth Factors and Growth Hormone in Reversing Catabolic States

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-term mortality in anorexia nervosa. A 20-year follow-up of the St George's and Aberdeen cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Prior treatment received by patients with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Treatment and outcome of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Binge eating in the obese

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Hypothalamic-pituitary-gonadal function in anorexia nervosa and bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Pituitary abnormalities in eating disorders: Further evidence from MRI studies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Increasing incidence of anorexia nervosa in the female population of northeast Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Reboxetine in the treatment of bulimia nervosa: a report of seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A placebo-controlled trial of d-fenfluramine in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Self-induced vomiting and bulimia nervosa: an undetected problem.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-Term Use of Fluoxetine in Bulimia Nervosa: A Retrospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

T-lymphocyte subsets in patients with abnormal body weight: longitudinal studies. in anorexia nervosa and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Case study: anorexia nervosa and autistic disorder in an adolescent girl.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Sertraline in underweight binge eating/purging-type eating disorders: five case reports

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Secret patterns: validation of a screening tool to detect bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Detection of bulimia in a primary care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The eating attitudes test: psychometric features and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effect of inositol on bulimia nervosa and binge eating

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Ipsapirone in the treatment of bulimia nervosa: an open pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Cyproheptadine in Anorexia Nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A double-blind controlled trial of lithium carbonate primary anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Dermatologic signs in anorexia nervosa and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Cyproheptadine for anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Olanzapine in the treatment of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A self-rating scale for bulimia. The 'BITE'

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Regional cerebral glucose metabolism in anorexia nervosa measured by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Treating bulimia with desipramine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Anorexia nervosa and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Anorexia nervosa: treatment with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Carbamazepine in the treatment of bulimia.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Zinc deficiency in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-term outcome of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Thyrotropin, prolactin, and growth hormone responses to thyrotropin-releasing hormone in anorexia nervosa and bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Eating disorders in children and adolescents: pharmacological therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Myocardial impairment resulting from eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Case reports of olanzapine treatment of anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Do primary care providers screen for eating disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Dissociation, childhood trauma, and the response to fluoxetine in bulimic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Zinc status before and after zinc supplementation of eating disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Treatment of anorexia nervosa with tramadol

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Leaflet to left ventricular size disproportion and prolapse of a structurally normal mitral valve in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Medical complications and medical management of bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The SCOFF questionnaire: assessment of a new screening tool for eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Mortality and sudden death in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Relationship of bone density to estradiol and cortisol in anorexia nervosa and bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Risperidone in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effect of hormone replacement therapy on bone density in a patient with severe osteoporosis caused by anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Mortality in eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Torsade de pointes induced by cisapride/clarithromycin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Role of interleukin-6 and transforming growth factor-β in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Bulimia treated with imipramine: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Anorexia nervosa: outcome and prognostic factors after 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Hypoglycemic coma in anorexia nervosa. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Bone mineral density and anorexia nervosa in women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The medical complications of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

The need for psychiatric-dental liaison in the treatment of bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Lithium in a case of severe anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A controlled trial of cisapride in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

A Case of Anorexia Nervosa with Acute Renal Failure Induced by Rhabdomyolysis; Possible Involvement of Hypophosphatemia or Phosphate Depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Fluoxetine for bulimia nervosa following poor response to psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Phenelzine vs placebo in 50 patients with bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Long-term outcome of antidepressant treatment for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Medication and psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Detection, evaluation, and treatment of eating disorders the role of the primary care physician

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Behavior therapy, pimozide treatment and prolactin secretion in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Phenytoin treatment of the binge-eating syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

Anorexia nervosa responding to zinc supplementation: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2801%2900012-8

7 January 2021

10.1016/S1056-4993(01)00012-8

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hkkkmt6l6bfh3kptld3ortxhsa

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_hkkkmt6l6bfh3kptld3ortxhsa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hkkkmt6l6bfh3kptld3ortxhsa

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/hkkkmt6l6bfh3kptld3ortxhsa

30 July 2022